TickerFacts.

Impact Biomedical Inc. (IBO): Revenue

Annual figures by period end, from SEC filings.

$32.0K
Year ended 2025-12-31
$35.0K
Trailing 12 months to 2026-06-30
-13.8%
3-year compound annual growth
$50.0K2022-12-31: $50.0K2025-12-31: $32.0K$32.0K
2022-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$32.0Kn/a2026-03-11, From 2025-01-01
No annual figure between 2022-12-31 and 2025-12-31.
2022-12-31$50.0Kn/a2024-02-20, From 2022-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Impact Biomedical Inc. (IBO)2025-12-31$32.0Kn/a
Lyell Immunopharma, Inc. (LYEL)2025-12-31$36.0K-41.0%
Talphera, Inc. (TLPH)2025-12-31$28.0Kn/a
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31$40.0K-51.8%
Altimmune, Inc. (ALT)2025-12-31$41.0K+105.0%
Jupiter Neurosciences, Inc. (JUNS)2025-12-31$21.8Kn/a
Skinvisible, Inc. (SKVI)2025-12-31$20.0K0.0%
Lunai Bioworks Inc. (LNAI)2026-06-30$52.0Kn/a
HCW Biologics Inc. (HCWB)2025-12-31$54.2K-97.9%

Compare IBO, LYEL, TLPH, NTHI side by side · Screen every company in Pharmaceutical Preparations ↗